Literature DB >> 16420749

Susceptibility and resistance to pneumococcal disease in mice.

Aras Kadioglu1, Peter W Andrew.   

Abstract

Although pneumococcus is a major pathogen of humans and, every year, the bacterium causes illness and death in millions of individuals, the genetic basis of susceptibility to the bacterium is unknown. Previous attempts to identify the gene explaining differing susceptibility to pneumococcal disease in humans have been without significant success. In order to develop new hypotheses that can be tested in humans, significant efforts have been made using mouse models of infection and disease. Indeed, the majority of the information so far obtained on pneumococcal disease in vivo has come from mouse studies. Mice differ in their response to pneumococcal disease, however, and the genetic basis of susceptibility to infection is unknown. This review summarises the current knowledge of mouse susceptibility and resistance to pneumococcal infection.

Entities:  

Mesh:

Year:  2005        PMID: 16420749     DOI: 10.1093/bfgp/4.3.241

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  15 in total

1.  Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.

Authors:  Xiuyu Xu; Jiangping Meng; Yiping Wang; Jie Zheng; Kaifeng Wu; Xuemei Zhang; Yibing Yin; Qun Zhang
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection.

Authors:  Xiuyu Xu; Hong Wang; Yusi Liu; Yiping Wang; Lingbing Zeng; Kaifeng Wu; Jianmin Wang; Feng Ma; Wenchun Xu; Yibing Yin; Xuemei Zhang
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.

Authors:  Keer Sun; Yan Gan; Dennis W Metzger
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

Review 4.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.

Authors:  D M Ferreira; M Darrieux; D A Silva; L C C Leite; J M C Ferreira; P L Ho; E N Miyaji; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

6.  B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.

Authors:  Deborah D Crane; Amanda J Griffin; Tara D Wehrly; Catharine M Bosio
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

7.  Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Danuta Radzioch; Serge Rivest; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

8.  Colonization of cecum is important for development of persistent infection by Yersinia pseudotuberculosis.

Authors:  Anna Fahlgren; Kemal Avican; Linda Westermark; Roland Nordfelth; Maria Fällman
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

9.  Neutrophils Are Required During Immunization With the Pneumococcal Conjugate Vaccine for Protective Antibody Responses and Host Defense Against Infection.

Authors:  Essi Y I Tchalla; Manmeet Bhalla; Elizabeth A Wohlfert; Elsa N Bou Ghanem
Journal:  J Infect Dis       Date:  2020-09-14       Impact factor: 5.226

10.  Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.

Authors:  Edel A McNeela; Aine Burke; Daniel R Neill; Cathy Baxter; Vitor E Fernandes; Daniela Ferreira; Sarah Smeaton; Rana El-Rachkidy; Rachel M McLoughlin; Andres Mori; Barry Moran; Katherine A Fitzgerald; Jurg Tschopp; Virginie Pétrilli; Peter W Andrew; Aras Kadioglu; Ed C Lavelle
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.